收藏切换
In vitro functional similarity assessment of a proposed biosimilar BAT1706 to bevacizumab
收藏切换
PDF
Chun-ping DENG, Hang CHEN, Ying-hua WANG, Shen-di LIANG, Di CAO, Jin-quan YU, Sheng-feng LI, Cui-hua LIU*
Acta Pharmaceutica Sinica | 2021, 56(7) : 1927 - 1935
Less
收藏切换
Acta Pharmaceutica Sinica | 2021, 56(7): 1927-1935
Original Articles
In vitro functional similarity assessment of a proposed biosimilar BAT1706 to bevacizumab
Full
Chun-ping DENG, Hang CHEN, Ying-hua WANG, Shen-di LIANG, Di CAO, Jin-quan YU, Sheng-feng LI, Cui-hua LIU*
Affiliations
  • Bio-Thera Solutions, Ltd., Guangzhou 510530, China
Published: 2021-07-12 doi: 10.16438/j.0513-4870.2021-0144
Outline
收藏切换

Biosimilars are biological medicinal products that are highly similar to an already licensed reference product in terms of quality, safety, and efficacy. BAT1706 is being developed by Bio-Thera Solutions, Ltd. as a proposed biosimilar candidate to bevacizumab reference product (Avastin®). Bevacizumab acts by specifically binding to vascular endothelial growth factor A (VEGF-A), and preventing the interaction of VEGF-A with its receptors on the surface of endothelial cells, then blocking the downstream signaling pathway mediated by ligand-receptor, and inhibiting endothelial angiogenesis, thus inhibiting tumor growth. Comprehensive analytical characterization studies incorporating orthogonal analytical techniques were performed to compare the in vitro functional activities of BAT1706 and Avastin®. BAT1706 and Avastin® showed highly similar binding activity to multiple VEGF-A isoforms and equivalent VEGF-A neutralizing activity, as well as inhibitory activity of VEGF receptor (VEGFR)-2 tyrosine kinase autophosphorylation. Both products exhibited similar binding of the Fcγ receptors and a lack of Fc-related effector functions such as antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). Overall, the results demonstrate that BAT1706 and Avastin® are highly similar in terms of in vitro functional activities.

vascular endothelial growth factor  /  bevacizumab  /  biosimilar  /  similarity  /  functional activity
Chun-ping DENG, Hang CHEN, Ying-hua WANG, Shen-di LIANG, Di CAO, Jin-quan YU, Sheng-feng LI, Cui-hua LIU. In vitro functional similarity assessment of a proposed biosimilar BAT1706 to bevacizumab[J]. Acta Pharmaceutica Sinica, 2021 , 56 (7) : 1927 -1935 . DOI: 10.16438/j.0513-4870.2021-0144
Year 2021 volume 56 Issue 7
PDF
136
50
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-0144
  • Receive Date:2021-01-28
  • Online Date:2025-12-18
  • Published:2021-07-12
Article Data
Affiliations
History
  • Received:2021-01-28
  • Revised:2021-03-26
Funding
Affiliations
    Bio-Thera Solutions, Ltd., Guangzhou 510530, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-0144
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT